Tracking CGEM historical volatility helps you see how much Cullinan Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Cullinan Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor CGEM 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The CGEM 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Cullinan Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Cullinan Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where CGEM HV is running hot, cold, or in line. Make the CGEM 30 day historical volatility — and every other window — work for your edge instead of against it.
